Two lab workers in front of QIAsymphony Connect

Automated clinical sample preparation

User experiences with QIAsymphony Connect

Here's how QIAsymphony users are putting their instruments to work and moving clinical research and testing forward

Improving lymphoma care with cfDNA-based minimal residual disease monitoring

Pr. Marie-Hélène Delfau-Larue, MD, PhD and her team at AP-HP in France are pioneers in the study of residual disease in lymphoma. Like many labs, they face the difficult task of extracting minute quantities of cell-free DNA (cfDNA) from patient samples. Hear why Delfau-Larue’s lab relies on QIAsymphony instruments to ensure success during this complex preanalytical step.

90% of current publications use QIAGEN technology to perform cfDNA extractions. So, given how satisfied I was with the instrument and the fact that I have no doubts about QIAGEN technology itself, if someone calls me saying, "I've tested it, I'm happy, what do you think?" I'd say, "Yeah, it's great."

Pr. Marie-Hélène Delfau-Larue, MD, PhD, Head of the Department of Hematology and Immunology, GHU Henri Mondor (AP-HP), France

Delivering population-wide non-invasive prenatal testing with automation

Each year, the Institute of Pathology and Genetics in Belgium processes up to 20,000 blood samples from pregnant women to detect chromosomal abnormalities. Learn how Jean-Martin Billard, MSc and his team use QIAsymphony instruments as the backbone of their cell-free DNA isolation workflow, helping make high-throughput NIPT screening possible.

The equivalency compared to the QIAsymphony SP is there... The QIAsymphony Connect helps us to have that traceability and to reduce the hands-on time for the extraction.

Jean-Martin Billard, MSc, Biologist, Institute of Pathology and Genetics, Belgium

Read the full story

Learn how Billard's lab uses QIAsymphony Connect to simplify the preanalytical step of NIPT screening.

Learn more

Standardizing the development of new minimal residual disease tests

Myriad Genetics develops highly sensitive MRD assays that depend on isolating concentrated, sequencing-ready cfDNA from plasma. Watch the video to see how QIAsymphony instruments help David Almanzar, PhD, and his team achieve the cfDNA quality and consistency needed to develop new assays and scale their testing.

It's really cool to be able to do something once or maybe ten times. But the real power comes from being able to do something 100 times, 1000 times, 10,000 times. This is something that we really appreciated about working with the QIAsymphony Connect platform. The platform was robust and the platform was consistent.

David Almanzar, PhD, Scientist, Myriad Genetics, USA

QIAsymphony Connect is easy to use – see for yourself

Working with precious clinical samples leaves little room for error. QIAsymphony Connect helps simplify setup with a user-friendly interface and step-by-step guidance, making it easier to generate high-quality DNA and RNA with confidence.

Try the online demo

Get all the specs on QIAsymphony Connect

QIAsymphony Connect can help with the day-to-day challenges of clinical nucleic acid isolation. It gives labs a more straightforward way to standardize extraction and keep things moving. Get up to speed on the technical specs of QIAsymphony Connect to see how it can support your lab.

See the product details

The testimonials included here reflect the speakers' independent observations and opinions, based on their experiences with the product during evaluation and use. Individual results may vary depending on workflow, sample type, protocol, application and implementation conditions.